Advertisement

HYPE Jumps 8% After $888 Million DAT Gets Approved

Sonnet BioTherapeutics will merge with Rorschach LLC to launch the first major HYPE treasury company.
By: Squiffs •
HYPE Jumps 8% After $888 Million DAT Gets Approved

Sonnet BioTherapeutics will merge with Rorschach LLC to launch the first major HYPE treasury company.

Loading this article…